Press Releases

MYOS CORP Enters Exclusive Agreement with Science Biotech to Distribute Fortetropin® Products in Australia and New Zealand
MYOS CORP, Formerly Known as Myos Rens Technology, Inc., Issues Notice to its Shareholders
MYOS CORP Announces Positive Results from Mobility and Quality of Life Study in Geriatric and Arthritic Dogs at Kansas State University
MYOS CORP Enters into Agreement with a Leading Hong Kong Supplement Distributor, Smart Supplement Ltd., to Distribute YOLKED® Sports Nutrition Products in Hong Kong and Southeast Asian Countries
MYOS Corp Receives a New Patent from the United States Patent and Trademark Office Significantly Enhancing its Musculoskeletal Health Intellectual Property Portfolio
MYOS RENS TECHNOLOGY BOARD OF DIRECTORS approved the Reverse Stock Split ratio of one new share for every 12 shares of Common Stock outstanding
MYOS RENS Technology Announces anticipated exchange ratio, immediately after the completion of the Merger
MYOS RENS Technology Announces Net Revenues Increase 39% for the Three Months Ended September 30, 2020
MYOS RENS Technology, Inc. Appoints The S3 Agency to Help Build Awareness of Muscle Health Importance
MYOS RENS Technology's Net Revenues Increase 114% and Operating Expenses Decrease 26% for the Three Months Ended June 30, 2020
RSS
Show All